RECEPIOS Trademark

Trademark Overview


On Monday, April 11, 2022, a trademark application was filed for RECEPIOS with the United States Patent and Trademark Office. The USPTO has given the RECEPIOS trademark a serial number of 97357986. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Friday, January 3, 2025. This trademark is owned by Vanda Pharmaceuticals Inc.. The RECEPIOS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatm...
recepios

General Information


Serial Number97357986
Word MarkRECEPIOS
Filing DateMonday, April 11, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateFriday, January 3, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 27, 2023

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment and prevention of motion sickness; Pharmaceutical preparations for the treatment and prevention of cravings for opioid substances or opiate substances; Pharmaceutical preparations for the treatment and prevention of nausea; Pharmaceutical preparations for the treatment and prevention of vomiting; Pharmaceutical preparations for the treatment and prevention of substance dependence; Pharmaceutical preparations for the treatment and prevention of anxiety; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by an over-expression of the neuropeptide known as substance P; Pharmaceutical preparations for the treatment and prevention of diseases, disorders, or conditions caused by overstimulation of the neurokinin-1 (NK-1) receptor; Pharmaceutical preparations for the treatment of gastroparesis; Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the treatment of atopic dermatitis; Pharmaceutical preparations for the treatment of pain; Pharmaceutical preparations for the treatment of psychiatric diseases and disorders; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 18, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameVanda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Party NameVanda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWashington, DC 20037

Trademark Events


Event DateEvent Description
Thursday, April 14, 2022NEW APPLICATION ENTERED
Monday, April 18, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 26, 2023ASSIGNED TO EXAMINER
Monday, February 6, 2023NON-FINAL ACTION WRITTEN
Monday, February 6, 2023NON-FINAL ACTION E-MAILED
Monday, February 6, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 3, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 3, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 4, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 23, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 27, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, June 7, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 27, 2023PUBLISHED FOR OPPOSITION
Thursday, February 1, 2024SOU TEAS EXTENSION RECEIVED
Saturday, February 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 22, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, February 1, 2024SOU EXTENSION 1 FILED
Thursday, February 1, 2024SOU EXTENSION 1 GRANTED
Wednesday, July 31, 2024SOU EXTENSION 2 FILED
Wednesday, July 31, 2024SOU EXTENSION 2 GRANTED
Thursday, January 2, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 3, 2025SOU EXTENSION 3 FILED
Friday, January 3, 2025SOU EXTENSION 3 GRANTED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED